Evidence map›Paper›PMID 29276749›Full record

ArticleCellular and molecular gastroenterology and hepatology2018

HIF-1α Deletion in the Endothelium, but Not in the Epithelium, Protects From Radiation-Induced Enteritis.

Aurore Toullec, Valérie Buard, Emilie Rannou, Georges Tarlet, Olivier Guipaud, Sylvie Robine, M Luisa Iruela-Arispe, Agnès François, Fabien Milliat

Abstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity.International journal of radiation oncology, biology, physics · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Targets for protection and mitigation of radiation injury.Cellular and molecular life sciences : CMLS · 2020
    Review
  14. Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Review
  15. Article
  16. Endothelial-to-Mesenchymal Transition in Cancer.Frontiers in cell and developmental biology · 2020
    Review
  17. Article
  18. Identification of a Novel HIF-1α-αFrontiers in immunology · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aurore ToullecResearch Laboratory of Radiobiology and Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Valérie BuardResearch Laboratory of Radiobiology and Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Emilie RannouResearch Laboratory of Radiobiology and Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Georges TarletResearch Laboratory of Radiobiology and Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Olivier GuipaudResearch Laboratory of Radiobiology and Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Sylvie RobineCurie Institute, Paris, France.
M Luisa Iruela-ArispeDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, California.
Agnès FrançoisResearch Laboratory of Radiobiology and Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Fabien MilliatResearch Laboratory of Radiobiology and Radiopathology, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsRadiation therapy in the pelvic area is associated with side effects that impact the quality of life of cancer survivors. Interestingly, the gastrointestinal tract is able to adapt to significant changes in oxygen availability, suggesting that mechanisms related to hypoxia sensing help preserve tissue integrity in this organ. However, hypoxia-inducible factor (HIF)-dependent responses to radiation-induced gut toxicity are unknown. Radiation-induced intestinal toxicity is a complex process involving multiple cellular compartments. Here, we investigated whether epithelial or endothelial tissue-specific HIF-1α deletion could affect acute intestinal response to radiation.

methodsUsing constitutive and inducible epithelial or endothelial tissue-specific HIF-1α deletion, we evaluated the consequences of epithelial or endothelial HIF-1α deletion on radiation-induced enteritis after localized irradiation. Survival, radiation-induced tissue injury, molecular inflammatory profile, tissue hypoxia, and vascular injury were monitored.

resultsSurprisingly, epithelium-specific HIF-1α deletion does not alter radiation-induced intestinal injury. However, irradiated VECad-Cre

conclusionsWe demonstrate

Indexed as

EndoMT, endothelial-to-mesenchymal transitionEndotheliumHIF-1αHIF-1αFl/FL, HIF-1α floxed miceHIF, hypoxia-inducible factorHIMEC, human intestinal microvascular endothelial cellsHUVEC, human umbilical vein endothelial cellsIL, interleukinPAI-1, plasminogen activator inhibitor type-1PCR, polymerase chain reactionRadiationROSA, ROSA26R LacZ reporter miceSham-IR, sham-irradiationTBI, total body irradiationVECad-Cre, VE-cadherin-Cre mice

Identifiers

PMID29276749
PMCPMC5738457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.